# Safety and Immunogenicity of Two Adjuvanted and One Non-adjuvanted H5N1 Influenza Vaccine in Adults

> **NCT00382187** · PHASE2 · COMPLETED · sponsor: **Novartis Vaccines** · enrollment: 40 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** MF59 adjuvanted H5N1 influenza vaccine

## Key facts

- **NCT ID:** NCT00382187
- **Lead sponsor:** Novartis Vaccines
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2016-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00382187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00382187, "Safety and Immunogenicity of Two Adjuvanted and One Non-adjuvanted H5N1 Influenza Vaccine in Adults". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00382187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*